Macquarie Bank Covered Warrant on RemeGen Co., Ltd. (23634)

Macquarie Bank Covered Warrant on RemeGen Co., Ltd. is a European-style call derivative warrant issued by Macquarie Bank Ltd., providing investors with leveraged exposure to the performance of RemeGen Co., Ltd. shares without owning the underlying asset. Known by its full name MBRMGEN@EC2608A, this standard cash-settled warrant allows holders the right, but not the obligation, to benefit from potential rises in RemeGen's stock price above the fixed strike level of HKD 99.95, calculated via a predetermined formula at exercise. Launched on December 15, 2025, and listed shortly thereafter, it matures on August 10, 2026, with an entitlement ratio of 100 warrants per underlying share, meaning 100 warrants are needed for the equivalent of one share's payout. Issued at HKD 0.250 with a total size of 40 million warrants and board lot size of 5,000, it trades in HKD and enables amplified market participation through gearing, where small premium investments can yield significant returns relative to direct share purchases, though with capped upside and full premium risk if unexercised. As a covered warrant, Macquarie Bank manages associated risks through hedging strategies, underscoring its role in Hong Kong's vibrant structured products market for targeted equity-linked opportunities.